223 related articles for article (PubMed ID: 8173185)
1. [In vitro characterization of S9788, a new modulator of multidrug resistance].
Pérez V; Pierré A; Léonce S; Anstett M; Prost JF; Atassi G
Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
[TBL] [Abstract][Full Text] [Related]
2. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.
Pérez V; Pierré A; Léonce S; Anstett M; Atassi G
Anticancer Res; 1993; 13(4):985-90. PubMed ID: 8352569
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological properties of S9788, a new modulator of multidrug resistance].
Bull Cancer; 1994 Feb; 81(2):93-103. PubMed ID: 7894124
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
[TBL] [Abstract][Full Text] [Related]
5. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry.
Sebille S; Morjani H; Poullain MG; Manfait M
Anticancer Res; 1994; 14(6A):2389-93. PubMed ID: 7825978
[TBL] [Abstract][Full Text] [Related]
6. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
Merlin JL; Marchal S; Ramacci C; Dieterlen A; Schultz G; Lucas C; Poullain MG; Berlion M
Cytometry; 1995 Aug; 20(4):315-23. PubMed ID: 7587719
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative cytological study of the activity of a new resistance modulator, S 9788, on human leukemic cells using multiparametric image analysis].
Oum'Hamed Z; Berlion M; Millot-Broglio C; Dufer J; Joly P; Bizzari JP; Desplaces A
Bull Cancer; 1994 Mar; 81(3):203-11. PubMed ID: 7894128
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.
Julia AM; Roché H; Berlion M; Lucas C; Milano G; Robert J; Bizzari JP; Canal P
Br J Cancer; 1994 May; 69(5):868-74. PubMed ID: 8180016
[TBL] [Abstract][Full Text] [Related]
9. Effects of verapamil and S9788 on MDR-1 mRNA expression studied by in situ hybridization.
Joly P; Lallemand A; Oum'Hamed Z; Trentesaux C; Idoine O; Desplaces A
Anticancer Res; 1996; 16(6B):3609-14. PubMed ID: 9042229
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro.
Hill BT; van der Graaf WT; Hosking LK; de Vries EG; Mulder NH; Whelan RD
Int J Cancer; 1993 Sep; 55(2):330-7. PubMed ID: 8103761
[TBL] [Abstract][Full Text] [Related]
11. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
Beck WT; Cirtain MC; Look AT; Ashmun RA
Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxicity of S16020-2, a new olivacine derivative.
Léonce S; Perez V; Casabianca-Pignede MR; Anstett M; Bisagni E; Pierré A; Atassi G
Invest New Drugs; 1996; 14(2):169-80. PubMed ID: 8913838
[TBL] [Abstract][Full Text] [Related]
14. New purines and purine analogs as modulators of multidrug resistance.
Dhainaut A; Regnier G; Tizot A; Pierre A; Leonce S; Guilbaud N; Kraus-Berthier L; Atassi G
J Med Chem; 1996 Sep; 39(20):4099-108. PubMed ID: 8831775
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Watanabe Y; Takano H; Kiue A; Kohno K; Kuwano M
Anticancer Drug Des; 1991 Feb; 6(1):47-57. PubMed ID: 2015041
[TBL] [Abstract][Full Text] [Related]
16. [Difference between the effects of S9788, verapamil and quinine on the reversion of multidrug resistance in two human tumor cell lines].
Bennis S; Robert J
Bull Cancer; 1994 Oct; 81(10):886-90. PubMed ID: 7734772
[No Abstract] [Full Text] [Related]
17. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
Arora A; Seth K; Kalra N; Shukla Y
Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
[TBL] [Abstract][Full Text] [Related]
18. Pervilleine F, a new tropane alkaloid aromatic ester that reverses multidrug resistance.
Mi Q; Cui B; Lantvit D; Reyes-Lim E; Chai H; Pezzuto JM; Kinghorn AD; Swanson SM
Anticancer Res; 2003; 23(5A):3607-15. PubMed ID: 14666656
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
20. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
Belhoussine R; Morjani H; Manfait M
Bull Cancer; 1997 Apr; 84(4):343-9. PubMed ID: 9238156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
